TrialPanorama/TrialPanorama-database huggingface dataset:
Study 37328178 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37328287 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 37328712 — Safety Biomarker (SAF): UGT1A1
Genes: UGT1A
Study 37328736 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 37328736 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 37328761 — Predictive Biomarker (PRD): RTEL1 mRNA
Genes: RTEL1; C20orf41; KIAA1088; NHL
Study 37328761 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37328835 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 37328859 — Surrogate Endpoint (SUR): Serum calcium
Study 37328890 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 37329361 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 37329361 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 37329423 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 37329633 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 37329633 — Surrogate Endpoint (SUR): Blood pressure
Study 37329889 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 37329891 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37330602 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 37331225 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 37331369 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 37331464 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study 37331928 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 37332340 — Surrogate Endpoint (SUR): Pathological complete response
Study 37332340 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 37332340 — Safety Biomarker (SAF): Platelet to lymphocyte
Study 37332615 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 37332638 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study 37333093 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study 37333093 — Safety Biomarker (SAF): T-cell specific protein RANTES
Genes: CCL5; D17S136E; SCYA5
Study 37333093 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 37333109 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 37333529 — Surrogate Endpoint (SUR): Blood pressure
Study 37333974 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study 37334358 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 37334358 — Predictive Biomarker (PRD): TREM1 mRNA
Genes: TREM1
Study 37334358 — Predictive Biomarker (PRD): IL1R2 mRNA
Genes: IL1R2; IL1RB
Study 37334358 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 37334511 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 37334673 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 37334784 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 37334864 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 37334864 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 37334864 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 37335970 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 37335970 — Predictive Biomarker (PRD): SCTR mRNA
Genes: SCTR
Study 37336055 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study 37336058 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 37336058 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 37336058 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 37336228 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study 37336535 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 37337059 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study 37337222 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 37337747 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study 37337860 — Surrogate Endpoint (SUR): Blood pressure
Study 37338150 — Predictive Biomarker (PRD): PARP1 mRNA
Genes: PARP1; ADPRT; PPOL
Study 37338150 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 37338150 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 37338150 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 37338154 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37338355 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 37338355 — Surrogate Endpoint (SUR): Forced vital capacity
Study 37338608 — Surrogate Endpoint (SUR): Bone mineral density
Study 37338729 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 37338729 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37338893 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 37338898 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study 37339167 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 37339167 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 37339167 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 1 beta
Genes: IL1B; IL1F2
Study 37339167 — Predictive Biomarker (PRD): OSM mRNA
Genes: OSM
Study 37339167 — Predictive Biomarker (PRD): TLR5 mRNA
Genes: TLR5; TIL3
Study 37339167 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 37339186 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 37339334 — Predictive Biomarker (PRD): CDC73 mRNA
Genes: CDC73; C1orf28; HRPT2
Study 37339342 — Safety Biomarker (SAF): Aminopeptidase N
Genes: ANPEP; APN; CD13; PEPN
Study 37339483 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 37339483 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 37339586 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 37339979 — Predictive Biomarker (PRD): TNFRSF9 mRNA
Genes: TNFRSF9; CD137; ILA
Study 37339979 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 37340213 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study 37340318 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 37340318 — Predictive Biomarker (PRD): TOMM20 mRNA
Genes: TOMM20; KIAA0016
Study 37340318 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study 37341586 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 37342189 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study 37343145 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study 37343623 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 37343745 — Predictive Biomarker (PRD): FN1 mRNA
Genes: FN1; FN
Study 37343745 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study 37344061 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 37344340 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 37344474 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 37344582 — Predictive Biomarker (PRD): RB1
Genes: RB; PPP1R130
Study 37344751 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 37344780 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 37344780 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 37344780 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study 37344825 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 37344895 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 37345196 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 37345196 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 37345834 — Surrogate Endpoint (SUR): Blood pressure
Study 37347393 — Predictive Biomarker (PRD): DST mRNA
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study 37347964 — Surrogate Endpoint (SUR): Blood pressure
Study 37348019 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37348019 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 37348348 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 37349083 — Safety Biomarker (SAF): miR-206
Genes: MIR206
Study 37349083 — Safety Biomarker (SAF): miR-182-5p
Genes: MIR182
Study 37349100 — Surrogate Endpoint (SUR): Pathological complete response
Study 37349694 — Surrogate Endpoint (SUR): Total kidney volume
Study 37349895 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 37350052 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 37350280 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 37350492 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 37350990 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 37351781 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37352144 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 37352211 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 37352262 — Predictive Biomarker (PRD): NRM mRNA
Genes: NRM; NRM29; UNQ555/PRO1112
Study 37352266 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 37352479 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 37352479 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 37352498 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 37352498 — Predictive Biomarker (PRD): CD27 mRNA
Genes: CD27; TNFRSF7
Study 37352498 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 37353154 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 37353154 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study 37353154 — Safety Biomarker (SAF): Pentraxin-related protein PTX3
Genes: PTX3; TNFAIP5; TSG14
Study 37353154 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study 37353154 — Predictive Biomarker (PRD): TFPI mRNA
Genes: TFPI; LACI; TFPI1
Study 37353270 — Predictive Biomarker (PRD): CXADR mRNA
Genes: CXADR; CAR
Study 37353278 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study 37353278 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 37353788 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 37353855 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 37353855 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37353855 — Surrogate Endpoint (SUR): Blood pressure
Study 37354146 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 37354146 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 37354546 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 37354546 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37354546 — Surrogate Endpoint (SUR): Serum creatinine
Study 37354554 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 37354762 — Surrogate Endpoint (SUR): Blood pressure
Study 37355526 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 37355526 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37356033 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study 37356038 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 37356515 — Predictive Biomarker (PRD): IDS mRNA
Genes: IDS; SIDS
Study 37356708 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 37357331 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study 37357331 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 37358640 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 37358859 — Predictive Biomarker (PRD): NUBP1 mRNA
Genes: NUBP1; NBP; NBP1
Study 37360864 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study 37361617 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 37363965 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 37363965 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37363965 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 37363965 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study 37363992 — Predictive Biomarker (PRD): Microsatellite instability
Study 37363992 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 37364000 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 37364218 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37364600 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 37364721 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 37365046 — Surrogate Endpoint (SUR): Blood pressure
Study 37365154 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37365557 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 37365583 — Predictive Biomarker (PRD): CDKN1B mRNA
Genes: CDKN1B; KIP1; p27
Study 37365583 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 37365596 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37365596 — Predictive Biomarker (PRD): Hormone receptor
Study 37365618 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 37366061 — Surrogate Endpoint (SUR): Blood pressure
Study 37366061 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 37366260 — Surrogate Endpoint (SUR): Blood pressure
Study 37366315 — Predictive Biomarker (PRD): Hormone receptor
Study 37368929 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37368929 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 37368929 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 37368929 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 37368929 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 37369099 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 37369125 — Surrogate Endpoint (SUR): Blood pressure
Study 37369421 — Surrogate Endpoint (SUR): Blood pressure
Study 37369602 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 37369826 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 37369826 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 37370032 — Predictive Biomarker (PRD): MYRF mRNA
Genes: MYRF; C11orf9; KIAA0954; MRF
Study 37370032 — Surrogate Endpoint (SUR): Pathological complete response
Study 37370135 — Surrogate Endpoint (SUR): Blood pressure
Study 37370204 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): GZMB mRNA
Genes: GZMB; CGL1; CSPB; CTLA1; GRB
Study 37372153 — Predictive Biomarker (PRD): IGHMBP2 mRNA
Genes: IGHMBP2; SMBP2; SMUBP2
Study 37372153 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study 37373853 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 37376989 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 37377385 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37377605 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 37378404 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 37378860 — Safety Biomarker (SAF): c-Jun N-terminal kinase
Study 37378860 — Surrogate Endpoint (SUR): Forced vital capacity
Study 37378860 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study 37378983 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study 37378983 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study 37379158 — Surrogate Endpoint (SUR): Pathological complete response
Study 37379430 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 37379430 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 37379495 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 37379502 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 37379764 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 37380091 — Predictive Biomarker (PRD): TBCB mRNA
Genes: TBCB; CG22; CKAP1
Study 37380301 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37381014 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 37381988 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study 37381988 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 37382961 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 37383243 — Predictive Biomarker (PRD): REL mRNA
Genes: REL
Study 37384412 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 37384848 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 37385272 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 37385280 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 37385724 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study 37385855 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 37385905 — Surrogate Endpoint (SUR): Serum potassium
Study 37385995 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study 37385995 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 37385995 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 37386016 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 37386016 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study 37386016 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 37386016 — Predictive Biomarker (PRD): Induced myeloid leukemia cell differentiation protein Mcl-1
Genes: MCL1; BCL2L3
Study 37386485 — Predictive Biomarker (PRD): C6 mRNA
Genes: C6
Study 37386512 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study 37387213 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 37387213 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 37387213 — Predictive Biomarker (PRD): TACSTD2 mRNA
Genes: TACSTD2; GA733-1; M1S1; TROP2
Study 37387272 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 37387272 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 37388640 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study 37388902 — Predictive Biomarker (PRD): YAP1 mRNA
Genes: YAP1; YAP65
Study 37388902 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 37390310 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 37390360 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 37390764 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 37390764 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 37390764 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 37390764 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 37390800 — Predictive Biomarker (PRD): MAF mRNA
Genes: MAF
Study 37390836 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 37391470 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 37391667 — Surrogate Endpoint (SUR): Forced vital capacity
Study 37391938 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 37393120 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 37393269 — Predictive Biomarker (PRD): FMOD mRNA
Genes: FMOD; FM; SLRR2E
Study 37393757 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 37393757 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 37394115 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 37394115 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study 37394627 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study 37394627 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 37394920 — Predictive Biomarker (PRD): F2RL3 mRNA
Genes: F2RL3; PAR4
Study 37395286 — Predictive Biomarker (PRD): LDLR mRNA
Genes: LDLR
Study 37395286 — Predictive Biomarker (PRD): TFPI mRNA
Genes: TFPI; LACI; TFPI1
Study 37395286 — Predictive Biomarker (PRD): TIMP4 mRNA
Genes: TIMP4
Study 37395586 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 37395780 — Predictive Biomarker (PRD): LSS mRNA
Genes: LSS; OSC